Insights · Tag
Harm Reduction
Harm reduction is not permission to use drugs without consequences. It is the honest admission that people use substances, that prohibition creates deadly markets, and that policy should prioritize keeping people alive long enough to recover. These essays explore what harm reduction looks like in practice. If you are new to this work, start with the Drug Legalization Series hub — then return here for essays tagged around harm reduction specifically.
-
Drug Legalization Series Part 25: Punishing Pain or Saving Lives — The Real Choice in Drug Policy Reform
Part 25 reframes drug policy as punishing pain or saving lives: public health, overdose prevention, treatment on demand, and risk-based regulation.
-
Drug Legalization Series Part 24: The Ethical Case for Regulation — What We Owe People We Know Will Use Drugs
Part 24 on drug legalization ethics: we owe regulation that cuts preventable death instead of outsourcing safety to a black market when use is inevitable.
-
Drug Legalization Series Part 23: What Failure Looks Like If We Don't Change: Projecting the Status Quo Forward
Part 23 models drug overdose death projections under today's laws, showing what failure may look like if we keep the status quo.
-
How Do I Quit Using Drugs Without Treatment?
How do I quit using drugs without treatment? Safety-first steps when rehab is unavailable, you are not ready for formal care, or fear keeps you from asking for help.
-
Drug Legalization Series Part 22: Public Buy-In Is Built, Not Waited For: How Public Opinion Actually Shifts on Uncomfortable Drug Policy
How leaders build public support for drug policy that feels uncomfortable first — and why public perception shapes what lawmakers pass and fund.
-
Drug Legalization Series Part 21: Drug Legalization Is Bipartisan: Political Reality, Not Political Fantasy
Part 21 explains why bipartisan drug policy reform is viable now and why regulated legalization is a public health and safety upgrade, not ideology.
-
Drug Legalization Series Part 20: Urgency Without Panic — Why This Can't Wait Another Decade
Part 20 explains why an overdose prevention strategy can't wait another decade, and lays out urgent, measurable steps that reduce death without panic.
-
Drug Legalization Series Part 19: This Is Already Being Administered — The Myth That Regulation Is Too Complex to Run
Part 19 argues regulation is already administered across health, safety, and controlled-substance systems — and how that capacity can scale responsibly.
-
Drug Legalization Series Part 18: Public Health, Not Moral Panic — Building a Public Health Drug Policy That Actually Reduces Harm
Part 18 makes the case for public health drug policy that replaces moral panic with overdose prevention, harm reduction, and treatment on demand.
-
Drug Legalization Series Part 17: Case Studies Without Cherry-Picking — What Worked, What Failed, and Why
Part 17 reviews drug decriminalization case studies across the U.S. and abroad to show what worked, what failed, and why — without cherry-picking.
-
Drug Legalization Series Part 15: Arguments Against Drug Legalization: The Hard Objections, Answered Directly
The strongest arguments against drug legalization deserve direct answers — pros and cons, youth access, public safety, and whether use rises.
-
Drug Legalization Series Part 14: A Regulated Pharmacy Model for High-Risk Substances
A regulated pharmacy model for high-risk substances could replace street chaos with standards, cut overdose risk, and connect people to treatment fast.
-
Drug Legalization Series Part 9: What Regulation Would Actually Look Like
Risk-based drug regulation in practice: supply control, age and potency limits, licensing, taxation, enforcement priorities, and recovery infrastructure.
-
Drug Legalization Series Part 8: Fear Is Not a Policy: The Known Failure vs the Imagined Risk
Part 8 explores fear-based drug policy, Oregon's Measure 110 results, and what effective drug policy would require in the legalization series.
-
Drug Legalization Series Part 4: What Drug Legalization and Regulation Actually Buys Us
Legalization and regulation isn't endorsement — a regulated supply with testing, labeling, fentanyl strips, and accountability prohibition can't deliver.
-
Drug Legalization Series Part 1.5: Legalization vs Decriminalization vs Regulation: Drug Policy Explained
Legalization isn't one policy. This post explains legalization vs decriminalization vs regulation — and what strict regulation delivers.
-
Drug Legalization Series Part 1: Drug Legalization Isn’t Endorsement. It’s Regulation and Harm Reduction.
Drug legalization isn’t endorsement. Part 1 explains why punishment fails, why reentry is deadly, and why harm reduction saves lives.